Pay-to-participate funding schemes in human cell and tissue clinical studies.
about
Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholdersClinical research: Should patients pay to play?ClinicalTrials.gov, stem cells and 'pay-to-participate' clinical studies.Unproven Stem Cell-Based Interventions: Advancing Policy through Stakeholder Collaboration.Identity and ownership issues in the regulation of autologous cells.Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation.
P2860
Pay-to-participate funding schemes in human cell and tissue clinical studies.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pay-to-participate funding schemes in human cell and tissue clinical studies.
@en
type
label
Pay-to-participate funding schemes in human cell and tissue clinical studies.
@en
prefLabel
Pay-to-participate funding schemes in human cell and tissue clinical studies.
@en
P2860
P356
P1476
Pay-to-participate funding schemes in human cell and tissue clinical studies.
@en
P2093
Douglas Sipp
P2860
P304
P356
10.2217/RME.12.75
P433
P577
2012-11-01T00:00:00Z